Ewch i’r prif gynnwys
 Rebecca Milton

Rebecca Milton

Research Associate - Trial Manager

Email
miltonrl1@cardiff.ac.uk
Telephone
+44 (029) +44 2068 7518
Campuses
702c, 7th Floor, Neuadd Meirionnydd, Heath Park, CF14 4YS

Trosolwg

I am a Research Associate / Trial Manager at the Centre for Trials Research (CTR) working on a number of research studies.

My current projects:

The POOL Study which is a study looking to establish the safety of waterbirths, this is led by School of Healthcare Sciences, Cardiff University and is based in the UK across 26 NHS sites.

PAN-COVID is a global registry led by Imperial College London, aiming to evaluate the association of suspected COVID-19 and confirmed SARS-CoV-2 infection in women in pregnancy with:
1. Miscarriage
2. Fetal growth restriction and stillbirth
3. Pre-term delivery
4. Vertical transmission

FEMUR III is definitive randomised controlled trial and economic evaluation of a community-based rehabilitation package following hip fracture led by Liverpool University, CTR oversee three NHS sites in South Wales.

I am leading a research grant looking at determinants of stillbirth in northern Nigeria, this has been funded by the Global Challenges Research Fund.

My previous work include:

BARNARDS (Burden of Antibiotic Resistance in Neonates from Developing Societies) which was led by Cardiff University and was a global study aiming to determine the incidence of sepsis in neonates from seven low- and middle income countries as well as to understand the burden of antibiotic resistance which was funded by The Gates Foundation.

A Tenovus funded research grant led by School of Healthcare Sciences; Improving the experience of out-patient cancer treatment for people with co-morbid dementia in Wales.

MITReG which was a Microbiology and Infection Translational Research Group led by Cardiff University funded by NISCHR.

My primary research interest is maternal and neonatal health. I am currently progressing a PhD by publication in this area of research.

Bywgraffiad

Education and Qualifications: 

  • 2016: PRINCE II – Project Management
  • 2013: MPH; Cardiff University
  • 2013: Bsc Nutrition, Physical Activity and Community Health; University of Glamorgan
  • 2010: Institute of Leadership and Management, Leading and Managing Teams

Grants:

  • Lead applicant: Network award for GCRF dissemination (Incidence and risk factors of stillbirth in Nigeria) (GCRF)
  • Co-applicant: BARNARDS: Burden of Antibiotic Resistance in Neonates from developing societies (Bill & Melinda Gates) and Incidence and risk factors of stillbirth in Northern Nigeria (Kano) (GCRF)

Anrhydeddau a Dyfarniadau

  • February 2020: GW4 Early Career Symposia Scheme (AMR)
  • April 2019: Outstanding contribution to international work through the Cardiff University MEDIC Star Awards.

Aelodaethau proffesiynol

  • UK Trial Managers Network (UKTMN)
  • NIHR-MRC Trials Methodology Research Partnership Global Health Working Group Member

Safleoedd academaidd blaenorol

  • 2018 - present: Research Assoicate / Trial Manager: CTR
  • 2015-2018: Project Manager: BARNARDS, Infection and Immunity, Cardiff University
  • 2014-2015: Research Assistant: Healthcare Sciences, Cardiff University
  • 2010-2015: Project Assistant: MITReG, Infection and Immunity, Cardiff University

Cyhoeddiadau

2021

2020

2019

2016

My current research:

The POOL Study which is a study looking to establish the safety of waterbirths, this is led by School of Healthcare Sciences, Cardiff University and is based in the UK across 26 NHS sites.

PAN-COVID is a global registry led by Imperial College London, aiming to evaluate the association of suspected COVID-19 and confirmed SARS-CoV-2 infection in women in pregnancy with:
1. Miscarriage
2. Fetal growth restriction and stillbirth
3. Pre-term delivery
4. Vertical transmission

FEMUR III is definitive randomised controlled trial and economic evaluation of a community-based rehabilitation package following hip fracture led by Liverpool University, CTR oversee three NHS sites in South Wales.

I am leading a research grant looking at determinants of stillbirth in northern Nigeria, this has been funded by the Global Challenges Research Fund.

My previous research with continuing outputs:

BARNARDS (Burden of Antibiotic Resistance in Neonates from Developing Societies) which was led by Cardiff University and was a global study aiming to determine the incidence of sepsis in neonates from seven low- and middle income countries as well as to understand the burden of antibiotic resistance which was funded by The Gates Foundation.